Topical Ankaferd Bloodstopper in the management of critical bleedings due to hemorrhagic diathesis Hemorajik diyatez varlıǧında gelişlen kritik kanamalarda Topikal Ankaferd Bloodstopper uygulamaları

Creative Commons License

Turgut M., Tutkun F., Celebi N., Muğlalı M., HAZNEDAROĞLU İ. C., GÖKER H.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.21, sa.3, ss.160-165, 2011 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 3
  • Basım Tarihi: 2011
  • Doi Numarası: 10.4999/uhod.09104
  • Dergi Adı: UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.160-165
  • Anahtar Kelimeler: Ankaferd, Bleeding, Hemorrhagic diathesis, Hemostasis
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Ankaferd BloodStopper® (ABS) is an herbal extract which has been used historically as a haemostatic agent in traditional Turkish medicine. ABS comprises of standardized mixture of herbs Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum and Urtica dioica. Basic effect mechanism of ABS is the formation of an encapsulated protein web which represents the focus points for the vital erythrocyte masses. The haemostatic effects have been demonstrated by in vitro and in vivo studies. The usage of ABS as a hemostatic agent in external hemorrhages and in dental treatment in humans constitutes the first hints on ABS's safety and efficacy in humans. A phase I randomized, double-blinded, cross-over, placebo controlled clinical study in healthy volunteers indicated the safety of ABS. The aim of this report is to depict hemostatic effects of ABS in critical bleedings due to hemorrhagic diathesis, refractory to conventional measures in distinct clinical settings.